Entrada Therapeutics Statistics
Total Valuation
TRDA has a market cap or net worth of $254.76 million. The enterprise value is $49.65 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TRDA has 36.03 million shares outstanding. The number of shares has increased by 2.44% in one year.
| Current Share Class | 36.03M |
| Shares Outstanding | 36.03M |
| Shares Change (YoY) | +2.44% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 1.83% |
| Owned by Institutions (%) | 44.60% |
| Float | 19.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 44.40 |
| Forward PS | 8.96 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.90, with a Debt / Equity ratio of 0.18.
| Current Ratio | 13.90 |
| Quick Ratio | 13.40 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -48.28% and return on invested capital (ROIC) is -277.73%.
| Return on Equity (ROE) | -48.28% |
| Return on Assets (ROA) | -26.84% |
| Return on Invested Capital (ROIC) | -277.73% |
| Return on Capital Employed (ROCE) | -55.80% |
| Weighted Average Cost of Capital (WACC) | 3.16% |
| Revenue Per Employee | $37,750 |
| Profits Per Employee | -$1.09M |
| Employee Count | 152 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TRDA has paid $962,000 in taxes.
| Income Tax | 962,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.01% in the last 52 weeks. The beta is -0.09, so TRDA's price volatility has been lower than the market average.
| Beta (5Y) | -0.09 |
| 52-Week Price Change | -9.01% |
| 50-Day Moving Average | 11.16 |
| 200-Day Moving Average | 9.37 |
| Relative Strength Index (RSI) | 37.07 |
| Average Volume (20 Days) | 717,282 |
Short Selling Information
The latest short interest is 1.51 million, so 4.18% of the outstanding shares have been sold short.
| Short Interest | 1.51M |
| Short Previous Month | 998,352 |
| Short % of Shares Out | 4.18% |
| Short % of Float | 7.74% |
| Short Ratio (days to cover) | 2.68 |
Income Statement
In the last 12 months, TRDA had revenue of $5.74 million and -$166.12 million in losses. Loss per share was -$4.00.
| Revenue | 5.74M |
| Gross Profit | -135.81M |
| Operating Income | -176.51M |
| Pretax Income | -165.16M |
| Net Income | -166.12M |
| EBITDA | -172.56M |
| EBIT | -176.51M |
| Loss Per Share | -$4.00 |
Full Income StatementBalance Sheet
The company has $254.86 million in cash and $49.75 million in debt, with a net cash position of $205.11 million or $5.69 per share.
| Cash & Cash Equivalents | 254.86M |
| Total Debt | 49.75M |
| Net Cash | 205.11M |
| Net Cash Per Share | $5.69 |
| Equity (Book Value) | 270.85M |
| Book Value Per Share | 7.52 |
| Working Capital | 247.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$131.70 million and capital expenditures $59,000, giving a free cash flow of -$131.64 million.
| Operating Cash Flow | -131.70M |
| Capital Expenditures | 59,000 |
| Depreciation & Amortization | 3.96M |
| Net Borrowing | n/a |
| Free Cash Flow | -131.64M |
| FCF Per Share | -$3.65 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -3,076.18% |
| Pretax Margin | -2,878.29% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TRDA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.44% |
| Shareholder Yield | -2.44% |
| Earnings Yield | -65.21% |
| FCF Yield | -51.67% |
Analyst Forecast
The average price target for TRDA is $19.50, which is 175.81% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.50 |
| Price Target Difference | 175.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 49.11% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TRDA has an Altman Z-Score of 0.65 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.65 |
| Piotroski F-Score | 1 |
